TOFACARE 11MG (Tofacitinib (11mg))

Tofacare 11 mg Tablet is indicated for the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating joint pain, tenderness, and swelling, primarily through its anti-inflammatory properties. Additionally, it may help to slow down the deterioration of bones and joints associated with these conditions. The tablet may be utilized alone or in conjunction with other treatments, depending on the prescribing physician’s assessment. It can be ingested with or without food, but it is advisable to take it consistently at the same time daily for optimal effect. The prescribed dosage will depend on the individual’s health status and concurrent medications. It is essential to follow your healthcare provider’s instructions and not to discontinue its use without medical advice, as this may exacerbate your condition. Patients may require blood tests prior to initiation of therapy, and this medication should not be started if there is any active infection present. It is crucial to inform your healthcare provider of any history of tuberculosis, shingles, or conditions affecting the kidneys or liver, among others, as Tofacare 11 mg Tablet can increase the risk of infections or worsen existing ones. This medication is not approved for individuals under the age of 18 and should only be used during pregnancy or breastfeeding if deemed necessary by your physician, who will continuously monitor your health.